• 1. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 2. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 3. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 4. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 5. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Oligopeptides

Cycloaspeptide D: A Comprehensive Overview

Cycloaspeptide D, also known by its CAS Registry Number 691363-62-9, is a cyclic peptide that has garnered significant attention in the scientific community due to its unique structural properties and potential applications in various fields. This compound belongs to the broader class of cyclopeptides, which are characterized by their cyclic backbone structure. Cycloaspeptide D has been extensively studied for its role in biological systems, particularly in the context of drug discovery and biotechnology.

The structure of Cycloaspeptide D is composed of amino acids linked in a cyclic manner, forming a stable and rigid framework. This structural rigidity contributes to its unique chemical properties, making it an ideal candidate for exploring novel therapeutic agents. Recent studies have highlighted the potential of Cycloaspeptide D in targeting specific cellular pathways, particularly those involved in neurodegenerative diseases. Researchers have demonstrated that Cycloaspeptide D can modulate key enzymes associated with Alzheimer's disease, offering a promising avenue for drug development.

In addition to its therapeutic potential, Cycloaspeptide D has also been investigated for its role in biomaterials science. Its ability to self-assemble into nanofibers has made it a valuable component in the development of advanced materials for tissue engineering. These nanofibers exhibit excellent biocompatibility and mechanical properties, making them suitable for applications such as artificial scaffolds for cell growth.

Recent advancements in synthetic chemistry have enabled the efficient synthesis of Cycloaspeptide D, overcoming previous challenges associated with its production. These methods include solid-phase synthesis and recombinant protein expression, both of which have significantly improved the scalability and cost-effectiveness of producing this compound. The availability of high-quality Cycloaspeptide D has facilitated large-scale studies, further elucidating its biological functions and potential applications.

One of the most exciting developments involving Cycloaspeptide D is its application in cancer research. Studies have shown that this compound can selectively target cancer cells while sparing healthy tissues, making it a potential candidate for targeted therapies. Preclinical trials have demonstrated promising results, with Cycloaspeptide D showing significant antitumor activity in various cancer models.

Beyond its direct applications in medicine and biotechnology, Cycloaspeptide D has also been utilized as a model system for studying peptide-protein interactions. Its well-defined structure makes it an ideal tool for investigating molecular recognition processes at the atomic level. This has led to new insights into how peptides interact with proteins, paving the way for the design of more effective therapeutic agents.

In conclusion, Cycloaspeptide D (CAS No. 691363-62-9) represents a fascinating compound with diverse applications across multiple scientific disciplines. From drug discovery to biomaterials science, this cyclic peptide continues to reveal new possibilities for advancing our understanding of biological systems and developing innovative solutions to complex challenges. As research into Cycloaspeptide D progresses, it is anticipated that this compound will play an increasingly important role in shaping the future of science and technology.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)